Efficacy of levamisole on experimental endometriosis

International Journal of Gynecology and Obstetrics

Volumn 99, Issue 1, 2007, Pages 38-42

  Ocal, G ^a   Kokcu, A ^a   Cetinkaya, M B ^a   Tosun, M ^a   Kefeli, M ^a   Kandemir, B ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Endometriosis; Leuprolide; Levamisole; Medroxyprogesterone acetate

Indexed keywords

LEUPRORELIN; LEVAMISOLE; MEDROXYPROGESTERONE ACETATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIOSIS; ENDOMETRIOTIC IMPLANT; FEMALE; IMPLANT; IMPLANTATION; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; RAT; TREATMENT DURATION;

EID: 34548321097     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2007.04.041     Document Type: Article

References (26)

1. Acien P., Quereda F., Campos A., Gomez-Torres M.J., Velasco I., and Gutierrez M. Use of intraperitoneal interferon α-2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trial. Fertil Steril 78 (2002) 705-711
2. D'Hooghe T.M., Debrock S., Hill J.A., and Meuleman C. Endometriosis and subfertility: is the relationship resolved?. Semin Reprod Med 21 (2003) 243-254
3. Braun D.P., Ding J., and Dmowski W.P. Peritoneal fluid mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-alpha in women with endometriosis. Fertil Steril 78 (2002) 727-732
4. D'Hooghe T.M., and Hill J.A. Immunology of endometriosis. In: Bronston R., and Anderson D.J. (Eds). Immunology of reproduction (1996), M.A. Blackwell Scientific, Cambridge 322-356
5. Dmowski W.P., Steele R.W., and Baker G.F. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol 141 (1981) 377-383
6. Steele R.W., Dmowski W.P., and Marmer D.J. Immunologic aspects of endometriosis. Am J Reprod Immunol 6 (1984) 33-36
7. Siristatidis C., Nissotakis C., Chrelias C., Iacovidou H., and Salamalekis E. Immunological factors and their role in the genesis and development of endometriosis. J Obstet Gynaecol Res 32 (2006) 162-170
8. Dmowski W.P., Gebel H.M., and Rawlins R.G. Immunologic aspects of endometriosis. Obstet Gynecol Clin North Am 16 (1989) 93-103
9. Braun D.P., Gebel H., Rotman C., Rana N., and Dmowski W.P. The development of cytotoxicity in peritoneal macrophages of women with endometriosis. Fertil Steril 57 (1992) 1203-1210
10. Keenan J.A., Williams-Boyce P.K., Massey P.J., Chen T.T., Caudle M.R., and Bukovsky A. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril 72 (1999) 135-141
11. Schenken R.S. Endometriosis. In: Scott J.R., Gibbs R.S., Karlan B.Y., and Haney A.F. (Eds). Danforth's obstetrics and gynecology. 9th edition (2003), Lippincott Williams and Wilkins, Philadelphia 714-720
12. D'Hooghe T.M., and Debrock S. Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons. Hum Reprod Update 8 (2002) 84-88
13. Ali A.F.M., Fateen B., Ezzet A., Badaway H., Ramadan A., and El-tobge A. Laparoscopic intraperitoneal injection of human interferon α-2b in the treatment of pelvic endometriosis: a new modality. Obstet Gynecol 95 (2000) S47-S48
14. Wheeler J.M., Knittle J.D., and Miller J.D. Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results. Am J Obstet Gynecol 167 (1992) 1367-1371
15. D'Hooghe T.M., Kyama C., Debrock S., Meuleman C., and Mwenda J.M. Future directions in endometriosis research. Ann N Y Acad Sci 1034 (2004) 316-325
16. Matalliotakis I.M., Arici A., Goumenou A.G., Katassos T., Karkavitsas N., and Koumantakis E.E. Comparison of the effects of leuprorelin acetate and danazol treatments on serum CA-125 levels in women with endometriosis. Int J Fertil Womens Med 49 (2004) 75-78
17. Ingelmo J.M., Quereda F., and Acien P. Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon-α-2b in a murine model. Fertil Steril 71 (1999) 907-911
18. Magri B., Vigano P., Rossi G., Somigliana E., Gaffuri B., and Vignali M. Comparative effect of the calcium antagonist verapamil and the synthetic steroids gestrinone and danazol on human monocyte phagocytosis in vitro. Gynecol Obstet Invest 43 (1997) 6-10
19. Waller K.G., and Shaw R.W. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril 59 (1993) 511-515
20. Bourinbaiar A.S., Lee-Huang S., Krasinski K., and Borkowsky W. Anti-HIV effect of immunomodulating agent, levamisole, in vitro. Biomed Pharmacother 48 (1994) 327-330
21. Kang Y., Jin H., Zheng G., Xie Q., Yin J., Yu Y., et al. The adjuvant effect of levamisole on killed viral vaccines. Vaccine 23 (2005) 5543-5550
22. Kocabas C.N., Sekerel B.E., Firat P.A., Okur H., and Adahoglu G. Levamisole: might it be used in treatment and prevention of atopic diseases?. J Asthma 41 (2004) 547-551
23. Friis T., Engel A.M., Klein B.M., Rygaard J., and Houen G. Levamisole inhibits angiogenesis in vitro and tumor growth in vivo. Angiogenesis 8 (2005) 25-34
24. Liu C.Y., Lai Y.Y., and Lo C.J. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells. J Surg Res 117 (2004) 223-231
25. Schiller J.H., Lindstrom M., Witt P.L., Hank J.A., Mahvi D., Wagner R.J., et al. Immunological effects of levamisole in vitro. J Immunother 10 (1991) 297-306
26. Startseva N.V., Baskakov V.P., Shvetsov M.V., and Kevorkov N.N. Use of levamisole in the complex treatment of patients with endometriosis. Akush Ginekol (Mosk) 11 (1985) 47-50